Buy FS3-P USB Triple Foot Switch Pedal Control Keyboard Mouse Plastic with fast shipping and top-rated customer service. Newegg shopping upgraded ™. Hub reduction Rigid FRDP-10 FR2P-20 FRDP-13 FR2P-26 FR3P-39 FRDP-14 FR2P-28 FRDP-16 FR2P-32 FR3P-48 FRDP-20 FR2P-41. Steerable Non Drive FSND-08 FSND-12-G. IKKEGOL PC USB Triple Foot Switch Keyboard Mouse Control Action 3 Three Pedal HID for Game PC Laptop Hospital (Triple 2M/6ft USB Cord) 4.1 out of 5 stars 156 $39.99 $ 39.
Back to Journals » International Journal of Nanomedicine » Volume 15
Authors Tran VA, Vo VG, Shim K, Lee SW, An SSA
Received17 March 2020
Accepted for publication 18 August 2020
Published 8 October 2020 Volume 2020:15 Pages 7667—7685
Checked for plagiarism Yes
Review bySingle anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo
Vy Anh Tran1,2 *,* Van Giau Vo3,4 *,* Kyuhwan Shim,5 Sang-Wha Lee,1 Seong Soo A An6
1Department of Chemical and Biological Engineering, Gachon University, Seongnam, Republic of Korea; 2NTTHi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh 700000, Vietnam; 3Institute of Research and Development, Duy Tan University, Danang 550000, Vietnam; 4Department of Industrial and Environmental Engineering, Graduate School of Environment, Gachon University, Seongnam 13120, Republic of Korea; 5Department of Neurology, Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea; 6Department of BioNano Technology, Gachon University, Seongnam 13120, Republic of Korea
*These authors contributed equally to this work
Correspondence: Sang-Wha Lee; Seong Soo A An
Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam 461-701, South Korea
Email [email protected]; [email protected]
Background: Core-shell types of mesoporous silica nanoparticles (MSNs) with multimodal functionalities were developed for bio-imaging, controlled drug release associated with external pH, and near-infrared radiation (NIR) stimuli, and targeted and effective chemo-photothermal therapeutics.
Materials and Methods: We synthesized and developed a core-shell type of mesoporous silica nanocarriers for fluorescent imaging, stimuli-responsive drug release, magnetic separation, antibody targeting, and chemo-photothermal therapeutics. Also, the biocompatibility, cellular uptake, cytotoxicity, and photothermal therapy on these FS3-based nanocarriers were systematically investigated.
Results: Magnetic mesoporous silica nanoparticles was prepared by coating a Fe3O4 core with a mesoporous silica shell, followed by grafting with fluorescent conjugates, so-called FS3. The resulting FM3 was preloaded with therapeutic cisplatin and coated with polydopamine layer, so-called FS3P/C. Eventually, graphene oxide-wrapped FS3P/C (FS3P-G/C) exhibited high sensitivity in the dual stimuli (pH, NIR)-responsive controlled release behavior. On the other hand, Au NPs-coated FS3P/C (FS3P-A/C) exhibited more stable release behavior, irrespective of pH changes, and exhibited much more enhanced release rate under the same NIR irradiation. Notably, FS3P-A/C showed strong NIR absorption, enabling photothermal destruction of HeLa cells by its chemo-photothermal therapeutic effects under NIR irradiation (808 nm, 1.5 W/cm2). The selective uptake of FS3-based nanocarriers was confirmed in cancer cell lines including HeLa (American Type Culture Collection - ATCC) and SHSY5Y (ATCC 2266) by the images obtained from confocal laser scanning microscopy, flow cytometry, and transmission electron microscopy instruments. Cisplatin-free FS3-based nanocarriers revealed good cellular uptake and low cytotoxicity against cancerous HeLa and SH-SY5Y cells, but showed no obvious toxicity to normal HEK293 (ATCC 1573) cell.
Conclusion: Along with the facile synthesis of FS3-based nanocarriers, the integration of all these strategies into one single unit will be a prospective candidate for biomedical applications, especially in chemo-photothermal therapeutics, targeted delivery, and stimuli-responsive controlled drug release against multiple cancer cell types.
Keywords: mesoporous silica NPs, Au NPs, stimuli-responsive drug release, chemo-photothermal therapy, cancerous cells
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]View Full Text [HTML]